PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Irvine-based Helio Genomics announces partnership with Quest Diagnostics to distribute its liver cancer detection test ...
Harbinger Health, a Cambridge biotech spun out of Flagship, says it has locked in $100 million in new financing as it races ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...
A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results